Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.7B | 1.6B | 1.6B | 1.7B |
Cost of revenue | 442M | 371M | 407M | 443M |
Gross profit | 1.3B | 1.3B | 1.2B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 191M | 186M | 174M | 177M |
Operating income | 174M | 186M | 187M | 275M |
Non operating interest income | ||||
Income | 85M | 86M | 76M | 84M |
Expense | 45M | 50M | 144M | 159M |
Other income expense | — | — | — | — |
Pretax income | 115M | 112M | 91M | 212M |
Tax provision | 28M | 37M | 26M | 44M |
Net income | 87M | 75M | 65M | 168M |
Basic EPS | 0.6 | 0.5 | 0.4 | 1.1 |
Diluted EPS | 0.6 | 0.5 | 0.4 | 1.1 |
Basic average shares | 145.5M | 147.4M | 147.8M | 147.7M |
Diluted average shares | 145.5M | 147.4M | 147.8M | 147.7M |
EBITDA | 361M | 363M | 429M | 565M |
Net income from continuing op. | 115M | 112M | 91M | 212M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |